Recent articles have reported elevated markers of coagulation, endothelial injury, and microthromboses in lungs from deceased patients with Covid-19. Platelets are critical in the formation of thrombi, and their most potent trigger is platelet-activating factor (PAF).

A recent exploration identified MK among the top-scoring clinically oriented drugs likely to inhibit SARS-CoV-2 main protease

Please sign in to read more